"Hospital particular (eletivo e emergência) gerido pela Santa Casa da Bahia. Oferece mais de 40 especialidades e serviços de alta complexidade. Atendimento SUS em Ambulatório com marcação pela Secretaria de Saúde (nos postos). Possui a certificação internacional HIMSS (Health Information and Management Systems Society) Nível 7 e a Qmentum Diamond, acreditação internacional canadense. Referência nacional e pioneiro no Nordeste, o Serviço de Cardiologia Intervencionista e Hemodinâmica do HSI, que já realizou mais de 100 mil procedimentos em 40 anos de atividade, possui Certificação Diamante por Distinção."

During the past decade, Hospital Santa Izabel conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Santa Izabel" #1 sponsor was "Pfizer" with 4 trials, followed by "Hospital Israelita Albert Einstein" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Santa Izabel" #1 collaborator was "CytoDyn, Inc." with 2 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "EMS S/A" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Santa Izabel" are "COVID-19 Pneumonia" (2 trials), "Crohn's Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "COVID-19" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Hospital Santa Izabel" in a lesser frequency.

Most popular intervention types in "Hospital Santa Izabel" are "Drug" (11 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Carboplatin" (2 trials), "Guselkumab" (2 trials), "Leronlimab" (2 trials) and "Belimumab 1 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Santa Izabel" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Santa Izabel". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Santa Izabel, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Santa Izabel, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".